Mindstrong Health, a startup focused on using smartphones to diagnose and aid in in the treatment of neuropsychiatric disorders, said it has secured $14 million in Series-A funding from investors that included Foresite Capital, ARCH Venture Partners, Optum Ventures and One Mind Brain Health Impact Fund.
"All modern medicine is based on objective measurement, yet tracking mental health has been limited to subjective reports in a clinical environment," Mindstrong Health founder and CEO Paul Dagum saud. "To improve outcomes for people with mental disorders, we need the kind of objective measures we have for other chronic diseases like diabetes and heart disease. Mindstrong's technology delivers continuous, objective measures of behavior and cognition at a level of resolution and insight that has never been possible."
Mindstrong has developed a platform that uses the patient's patterns of scrolling and typing on a smartphone to measure brain function. The platform provides information about the mood and cognition biomarkers, which include processing speed, memory and function.
"Mindstrong Health's founding team brings unmatched understanding of the critical challenges surrounding the way in which the medical community cares for patients suffering from cognitive health disorders," Foresite Capital CEO and Managing Director Jim Tananbaum said in the release.